Komori
Kringle Pharma (4884) · InitiativeRestatedLatest Other Disclosures (2026-10-07): "Advanced"

Open innovation for new research themes using HGF protein

First written in FY2022. 6 of 8 entries say "Restated". Latest entry: 2026-10-07.

8entries
5years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022 – FY2025-H12022: 12023: 320232024: 220242025: 120252026: 12026
Same theme, other companies
Call for Open Innovation Research Proposals on HGF ProteinA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. 2026-10-07AdvancedOther Disclosures

    「当社との事業提携、共同研究、ライセンス、投資等にご関心をお持ちの皆様のご来場を心よりお待ちしております。」

    JHVS 2026への出展を通じ、事業提携、共同研究、ライセンス、投資等の連携先を募る活動を具体化した。
  2. FY2025-H1RestatedAnnual report

    「In September 2022, we decided to promote open innovation by soliciting a broad range of researchers for new research themes utilizing HGF protein, in order to pursue the protein’s further potential.」

    幅広い研究者からHGFタンパク質の新たな研究テーマを募集するオープンイノベーション方針を再掲している。
  3. FY2024-Q2RestatedAnnual report

    「In September 2022, we decided to promote open innovation by soliciting a broad range of researchers for new research themes utilizing HGF protein, in order to pursue the protein’s further potential.」

    幅広い研究者からHGFタンパク質の新しい研究テーマを募集するオープンイノベーション方針を再掲している。
  4. FY2024-Q1RestatedAnnual report

    「In September 2022, we decided to promote open innovation by soliciting a broad range of researchers for new research themes utilizing HGF protein, in order to pursue the protein’s further potential.」

    幅広い研究者からHGFタンパク質の新しい研究テーマを募集するオープンイノベーション方針を再掲している。
  5. FY2023-Q3RestatedAnnual report

    「In September 2022, we decided to promote open innovation by soliciting a broad range of researchers for new research themes utilizing HGF protein, in order to pursue the protein’s further potential.」

    幅広い研究者からHGFタンパク質の新しい研究テーマを募集するオープンイノベーション方針を再掲している。
  6. FY2023-Q2RestatedAnnual report

    「In September 2022, we decided to promote open innovation by soliciting a broad range of researchers for new research themes utilizing HGF protein, in order to pursue the protein’s further potential.」

    幅広い研究者からHGFタンパク質の新しい研究テーマを募集するオープンイノベーション方針を再掲している。
  7. FY2023-Q1RestatedAnnual report

    「In September 2022, we decided to promote open innovation by soliciting a broad range of researchers for new research themes utilizing HGF protein, in order to pursue the protein’s further potential.」

    幅広い研究者からHGFタンパク質の新たな研究テーマを募集するオープンイノベーション方針を再掲している。
  8. FY2022First statedAnnual report

    「In September 2022, we decided to promote open innovation by soliciting a broad range of researchers for new research themes utilizing HGF protein, in order to pursue the protein’s further potential.」

    The company decided to promote open innovation by soliciting new research themes from a broad range of researchers to explore the further potential of HGF protein.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Kringle Pharma yet. It last moved in the Other Disclosures of 2026-10-07: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Open innovation for new research themes using HGF protein | Kringle Pharma,Inc. (4884) | Komori